Literature DB >> 22450880

A case of primary cutaneous anaplastic large cell lymphoma with prominent epidermotropism.

Tomomitsu Miyagaki1, Makoto Sugaya, Akie Miyamoto, Kunihiko Tamaki, Satoshi Ota, Shinichi Sato.   

Abstract

Primary cutaneous anaplastic large cell lymphoma (PCALCL) is defined as anaplastic large cell lymphoma localized to the skin without extracutaneous involvement at the time of diagnosis. Histologically, PCALCL is characterized by a dense nodular infiltrate of large lymphocytes, extending into the deep dermis or subcutis. Epidermotropism is sometimes, but not frequently, seen. We herein report a case of PCALCL with prominent epidermotropism. A 63-year-old Japanese woman was referred to our hospital with a red nodule and indurated erythema in 1997. Histological findings of a skin biopsy specimen from a red nodule were typical of PCALCL, however, biopsy specimens from indurated erythema showed remarkable epidermotropism. Tumor cells were positive for CD4, and CD30, but negative for CD3 and CD8. She was diagnosed with PCALCL. In 2007, skin biopsy was performed again, which showed large atypical lymphocytes in the upper dermis with mild epidermotropism. Tumor cells expressed in both CC chemokine receptor 4 and CXC chemokine receptor 3, which may explain prominent epidermotropism in this case.

Entities:  

Mesh:

Year:  2012        PMID: 22450880     DOI: 10.1007/s12185-012-1062-5

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  11 in total

1.  Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.

Authors:  T Yamaguchi; K Ohshima; K Karube; R Kawano; J Nakayama; J Suzumiya; M Kikuchi
Journal:  Br J Dermatol       Date:  2006-05       Impact factor: 9.302

2.  Small cell variant of CD30+ primary cutaneous T-cell lymphoma with epidermotropism that completely regressed after incisional skin biopsy.

Authors:  T Kamiya; K Saga; K Yanagisawa; R Kaneko; T Yamashita; O Ishida; K Jimbow
Journal:  Br J Dermatol       Date:  2006-08       Impact factor: 9.302

Review 3.  CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators.

Authors:  Werner Kempf
Journal:  J Cutan Pathol       Date:  2006-02       Impact factor: 1.587

4.  Pagetoid reticulosis (Woringer-Kolopp disease): an immunophenotypic, molecular, and clinicopathologic study.

Authors:  B Haghighi; B R Smoller; P E LeBoit; R A Warnke; C A Sander; S Kohler
Journal:  Mod Pathol       Date:  2000-05       Impact factor: 7.842

5.  Ki-1 (CD30) positive cutaneous anaplastic large cell lymphomas.

Authors:  P Kaudewitz; G Burg; H Stein
Journal:  Curr Probl Dermatol       Date:  1990

6.  Chemokine receptor expression in cutaneous T cell and NK/T-cell lymphomas: immunohistochemical staining and in vitro chemotactic assay.

Authors:  Hiroaki Yagi; Naohiro Seo; Akihiro Ohshima; Taisuke Itoh; Natsuho Itoh; Takahiro Horibe; Yasushi Yoshinari; Masahiro Takigawa; Hideo Hashizume
Journal:  Am J Surg Pathol       Date:  2006-09       Impact factor: 6.394

Review 7.  WHO-EORTC classification for cutaneous lymphomas.

Authors:  Rein Willemze; Elaine S Jaffe; Günter Burg; Lorenzo Cerroni; Emilio Berti; Steven H Swerdlow; Elisabeth Ralfkiaer; Sergio Chimenti; José L Diaz-Perez; Lyn M Duncan; Florent Grange; Nancy Lee Harris; Werner Kempf; Helmut Kerl; Michael Kurrer; Robert Knobler; Nicola Pimpinelli; Christian Sander; Marco Santucci; Wolfram Sterry; Maarten H Vermeer; Janine Wechsler; Sean Whittaker; Chris J L M Meijer
Journal:  Blood       Date:  2005-02-03       Impact factor: 22.113

8.  Pagetoid reticulosis with CD30 positivity and cytotoxic/suppressor cells.

Authors:  Witold K Jacyk; Wayne Grayson; Jurgen Erich Dinkel; Luis Requena
Journal:  J Cutan Pathol       Date:  2007-08       Impact factor: 1.587

9.  A case of Woringer-Kolopp disease with Ki-1 (CD30) + cytotoxic/suppressor cells.

Authors:  B R Smoller; M Stewart; R Warnke
Journal:  Arch Dermatol       Date:  1992-04

10.  Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma.

Authors:  Martin Kleinhans; Adrian Tun-Kyi; Michel Gilliet; Marshall E Kadin; Reinhard Dummer; Günter Burg; Frank O Nestle
Journal:  Blood       Date:  2002-09-26       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.